Narrator: This is Science Today. Every year, lung cancer kills more American men and women than breast, prostate and colon cancers combined. And yet, from a research standpoint, of all the cancers studied, lung cancer is the least funded. Dr. Angela Davies, of the University of California , Davis Cancer Center , says one reason is lung cancer does not have strong advocacy groups.
Davis : I think there are a number of potential reasons why lung cancer doesn't have a strong advocacy group such as breast cancer or HIV/AIDS for example. One would be the stigma associated with lung cancer from smoking and the direct relationship of smoking to lung cancer.
Narrator: Davies says the other potential reason for the lack of strong advocacy is that lung cancer patients do not live long enough.
Davies: Patients are often very ill; the therapies cause many side effects and they die very quickly, so that we're really not able to develop these advocacy groups.Narrator: For Science Today, I'm Larissa Branin.